Net profit of Elder Pharmaceuticals declined 5.99% to Rs 17.12 crore in the quarter ended March 2012 as against Rs 18.21 crore during the previous quarter ended March 2011. Sales rose 9.09% to Rs 244.14 crore in the quarter ended March 2012 as against Rs 223.79 crore during the previous quarter ended March 2011.
For the unaudited full year, net profit rose 20.98% to Rs 85.64 crore in the year ended March 2012 as against Rs 70.79 crore during the previous year ended March 2011. Sales rose 17.28% to Rs 981.89 crore in the year ended March 2012 as against Rs 837.19 crore during the previous year ended March 2011.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2012 | Mar. 2011 | % Var. | Mar. 2012 | Mar. 2011 | % Var. |
| Sales | 244.14 | 223.79 | 9 | 981.89 | 837.19 | 17 |
| OPM % | 19.30 | 21.68 | -11 | 21.39 | 20.52 | 4 |
| PBDT | 27.43 | 30.55 | -10 | 140.67 | 120.94 | 16 |
| PBT | 23.57 | 23.06 | 2 | 113.52 | 94.07 | 21 |
| NP | 17.12 | 18.21 | -6 | 85.64 | 70.79 | 21 |